The 4th Annual Executing Global Clinical Trials conference is on September 18, 2013, at the The Fairmont Hotel in Boston. Experienced Pharma and Biotech presenters addresses how to reduce the complexities of global trials and how to be more efficient and develop higher quality data at less cost.

New for this year is a panel comprised of case studies and lessons learned from unsuccessful global clinical trials in a time of welcoming collaboration and shared experiences.

Also featured:

• Global regulatory and emerging market updates
• Trends in audit inspections
• Stats on approvals outside the US and how these can help us make decisions on where to conduct global studies
• How companies are re-thinking global clinical trials and partnering with investigative sites
• Global CRO update on collaboration, implementation and execution of multi-national trials
• Update on risk based monitoring for global clinical trials
• A review on innovative technologies that drive efficiencies in global trials.
• Designing patient-centric protocols to increase global patient engagement
• Reducing protocol complexity
• Re-thinking global patient recruitment and the patient experience in global clinical trials.

The annual regional roundtables, where global clinical trial leaders with experience on the ground and expertise in different countries will address regulatory environments; how to work globally with different regulatory agencies; patient recruitment, enrollment and engagement; site selection; government protection of intellectual property; market access; cultural differences and idiosyncrasies; and key questions for CROs.

http://theconferenceforum.org/conferences/executing-global-clinical-trials/overview/

15% discount off program with code CW15

Led by Pfizer, Novartis, and Janssen this groundbreaking conference delivers only disruptive approaches, models and technologies to change the pace of clinical trials. Dpharm attracts creative thinkers from the scientific and operational aspects of clinical trials. It is designed to inspire the imagination and ambition of those who seek to innovate the clinical research discipline. This conference offers a fresh new format and is highly engaging with a style similar to TED events, but with live demos and interviews. The conference addresses:

• Challenges and opportunities in clinical development/trials
• Innovations in science applied to clinical development/trials
• Innovations in technology applied to clinical development/trials
• Disruptive models for clinical development/trials

15% discount off program with code CW15

http://theconferenceforum.org/conferences/disruptive-innovations/overview/

Clinical Trials built with adaptive designs can optimize drug development with much more efficient decision making. Adaptive designs have saved companies more than tens of millions of dollars per year. They can provide a window to see if clinical trials are on track. Adaptive Clinical Trials can:

• Reduce costs significantly
• Reduce risk in drug development
• Determine more appropriate dose selection
• Shorten development timelines
• Provide quality information
• Increase the value of the late stage portfolio
• Increase the success rate of the products in the portfolio

The FDA recognizes these benefits and understands that there are barriers to accomplishing adaptive designs. This one day Summit brings attendees through the reality of the barriers and suggested solutions, an understanding of the regulatory landscape, benefits, options and how to best implement adaptive designs. The format of the Summit is highly interactive with roundtables, break-outs and networking time built in throughout the day. This program will be offered as a stand alone event or as an optional pre-conference event to the 3rd annual Disruptive Innovations to Advance Clinical Trials conference which takes place the following two days.

10% off registration fee with code CW10

http://theconferenceforum.org/conferences/adaptive-clinical-designs/registration-pricing/

www.sitesolutionssummit.com

Site, Sponsor, and CRO executives are partnering for success at this year's Site Solutions Summit. More than 500 attendees will gain the takeaways their organizations need for ensuring partnership and project success.

Sponsors and CROs depend on the Summit to find the industry's highest performing sites, and share best practices for effective research relationships. Invest in your clinical research business, and reserve your seat today!

2013 Sponsor & CRO Attendees

(This list continues to grow, please visit www.sitesolutionssummit.com to view the most current list.)

Sponsors and CROs should contact Denise Davis at 410-696-5080 x 107 or denise.davis@myscrs.org to receive their complimentary registration.

Visit our video testimonials and learn why other sites attend the Summit.

View the agenda including: new master workshops, networking opportunities, roundtable and training sessions here.

Join the conversation, and help us improve the connections and outcomes between sites and industry!

We are 75% Sold Out. Don’t wait - Register at www.sitesolutionssummit.com.

For more information, please contact Barry Wood, Membership Director, at 410-696-5080 Ext. 120 or barry.wood@myscrs.org.

http://www.algopharm.com/en_ca/boston_2013/register

This complimentary Scientific Symposium is designed for the New England Pharmaceutical and Biopharmaceutical communities. The goal for this meeting is to create a forum for the exchange of ideas on drug development and biomedical research. The Symposium (17:00 – 19:15 | October 9th, 2013) will include presentations from industry experts on early phase drug development covering both clinical and bioanalytical perspectives.

Topics will include:

• Defying Circular Logic in Venture Capital: Raising Risk Capital for Early Stage Assets in a World that Values Clinical Data
Dr. Corey McCann, Principal, MPM Capital

• Key Considerations for Developing Efficient First-in-Human (FIH) Clinical Trials: A Case study Analysis
Dr. Marc Lefebvre, Vice-President, Scientific & Regulatory Affairs, Algorithme Pharma

• Technical and Operational Challenges of Designing Clinical Studies in Ultra Rare Disease Drug Development
Dr. Mike Collins, Vice-President, Global Clinical Operations, Alexion Pharmaceuticals

• Overcoming Bioanalytical Challenges During Clinical Sample Collections
Dr. Fabio Garofolo, Vice-President, Bioanalytical Services, Algorithme Pharma

For additional registration support, please contact us at ScienceExchange@algopharm.com or call David Leroux-Petersen at (514) 349-9649.

Building on the overwhelming success of our inaugural spring 2013 conference in Boston, CenterWatch and iiBIG’s inaugural fall 2013 forum in Las Vegas will continue to focus on innovative strategies and cutting-edge solutions to optimize clinical research performance and drive future success through novel collaboration and competitive differentiation.

With more than 50 workshops, panel sessions and roundtable discussions — including 20+ NEW topics for the Fall program — this conference brings together leaders from across the clinical research industry and offers hard-hitting, high-quality, relevant presentations based in large part on the strategic, data-driven and substantive reports and market analyses from The CenterWatch Monthly and CWWeekly publications.

The CenterWatch team has developed a unique agenda organized across three primary tracks:

• Track A: Innovative Strategies
  Leadership, Innovations and Global Solutions
• Track B: Operating Practices and Efficiencies
  Real-world Case Studies and Practical How-tos for Sponsors, Sites, CROs and Everyone in Between
• Track C: Effective Oversight and Regulation
  FDA, Medicare, Medicaid, Subject Protection and more

Plus, attendees, exhibitors and presenters will have ample networking and business development opportunities during the networking breaks and evening receptions to generate new contacts and clinical research partners.

For more information visit: http://www.iibig.com/conferences/P1302/overview.html

Over 500 people will attend. Register now while space is still available. Find out for yourself why 99% of participants are satisfied with MAGI conferences. See participating organizations.

90+ sessions and workshops in seven tracks: sponsor operations, site operations, regulatory compliance, contracts, budgets & billing, quality and special topics.
Exceptional networking with a broad (but not too broad) range of experienced clinical research professionals
23+ continuing education contact hours (CME, CNE, CLE, CCB, other)
Clinical Research Contract Professional (CRCP) certification exam

Sign Up Today and Save with:
Discounts for study sponsors, sites, government, international and others
All workshops included in basic registration
Save even more with group rates!
Obtain practical tips and professional contacts that will pay for the conference in a matter of days. Read article: "Does It Pay to Attend Clinical Research Conferences?" Adapt attendance approval request letter.

If you are a clinical research novice or veteran; with a study sponsor, research site, or CRO; in a corporate, academic or other organization; you will find a coherent and comprehensive program that focuses on your current needs for applicable information. MAGI sessions and workshops emphasize practical tips based on real-life examples, with lots of interaction. Please join us in Las Vegas.

Attendees Prefer MAGI Conferences
81% find the conference offers better value than other conferences.
79% find the conference more educational than other conferences.
78% find the networking better than at other conferences.
87% find the conference more practical than other conferences.
84% find the conference friendlier than other conferences.

About MAGI. MAGI is streamlining clinical research by standardizing best practices for clinical research operations, business and regulatory compliance. Our 10,000+ members represent clinical research sponsors, sites and CROs. "MAGI" is pronounced with "G" as in Georgia and "I" as in Ireland. (Hear it pronounced.) Norman M. Goldfarb, CRCP, founder and chairman of MAGI, is organizing and chairing this conference. Learn more.

MAGI is operated by First Clinical Research LLC.

https://www.magiworld.org/events/2013W/registration.php

Budgets continue to remain tight and in the current culture of doing more with less, metrics have never been more critical to assess performance and ensure quality and efficiency. Across the industry pharma is looking to quality agreements and partnership metrics to drive quality, while top leaders are championing industry standards for benchmarking in clinical development. This comes at the same time that the FDA is steering the industry toward risk-based monitoring to improve clinical quality and compliance where it impacts upon patient safety. What kinds of savings will you realize when you implement site selection metrics? Are you confident that you’ve selected the right metrics to measure and assess performance to identify areas for improvement to improve quality, increase efficiency and maximize performance?

Top Five Reasons to Attend

1. Receive a complementary CRO Quality Benchmarking - Phase II/III Service Providers (2013) report courtesy of Industry Standard Reports
2. Gain a range of strategies for effective partnership metrics, from governance structures to quality agreements
3. Hear how a top pharma company implemented KPI dashboards to drive process improvement and change management
4. Identify key areas subject to audits and inspections and put metrics in place to assess trial compliance
5. Find out which areas the industry is focusing on and what metrics standards the industry is moving toward

http://www.exlpharma.com/metrics

Organizer: Deliver Consulting Limited
Supporters: Society for Clinical Trials, Sino-American Pharmaceutical Professionals Association (Greater-Philadelphia)

"Asian Regional Drug Development Summit 2014" is the leading convention, providing the comprehensive discussions and updates on the Asian Regional Regulatory, Operational and Logistical Strategies and Practices when planning, initiating and performing the drug development programs especially the multinational studies in Asia Pacific. It is estimated to bring over 50 speakers and 200 clinical professionals from pharmaceutical and biotechnology companies, academics and institutions, investigational sites, regulatory agencies and mainly products, solutions and services companies to discuss on:

• Regional Regulatory Harmonization and Development Strategies
• Regional Clinical Operation and Project Management
• Drug Safety, Clinical Data Collection & Management and Supply Chain
• Develop the Close, Flexible, Strategic and Innovative Partnership
• Orphan Drug and Biosimilar Development in Asia
• Novel Theories, Clinical Innovation and Quality Management
• Novel Biomarkers and Genomics Tools

For more details and enquiries, please contact

Wei Zhang
Project Manager
wzhang@deliver-consulting.com
+86 21 6034 0229